Location History:
- Dallas, TX (US) (2010 - 2011)
- Haifa, IL (2013 - 2016)
- St. Louis, MO (US) (2015 - 2022)
Company Filing History:
7 out of 93 
1 out of 1,745 
1 out of 5,094 
Years Active: 2010-2022
Title: Eynav Klechevsky: Innovator in Immunology and Disease Modulation
Introduction
Eynav Klechevsky is a prominent inventor based in Haifa, Israel, known for his significant contributions to the field of immunology. With a total of nine patents to his name, he has made remarkable strides in developing methods and compositions that enhance our understanding and treatment of various diseases.
Latest Patents
Among his latest patents is the invention titled "Detection of CD5 and methods and compositions for modulating CD5." This patent provides innovative methods for modulating CD5 in subjects, which can be crucial for detecting and monitoring diseases, particularly inflammatory and autoimmune conditions. Another notable patent is focused on "Vaccines directed to Langerhans cells." This invention includes isolated anti-Langerin vaccines and outlines methods for creating and utilizing these vaccines, which are designed to deliver antigenic peptides effectively.
Career Highlights
Eynav Klechevsky has worked with esteemed organizations such as Baylor Research Institute and the Institut National de la Santé et de la Recherche Médicale. His work in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Throughout his career, Eynav has collaborated with notable professionals in the field, including Jacques F. Banchereau and Gerard Zurawski. These collaborations have further enriched his research and development efforts.
Conclusion
Eynav Klechevsky's innovative work in immunology and disease modulation has led to significant advancements in medical science. His patents reflect a commitment to improving health outcomes through targeted therapies and vaccines.